Cargando…
Computational modeling of sphingolipid metabolism
BACKGROUND: As suggested by the origin of the word, sphingolipids are mysterious molecules with various roles in antagonistic cellular processes such as autophagy, apoptosis, proliferation and differentiation. Moreover, sphingolipids have recently been recognized as important messengers in cellular...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537549/ https://www.ncbi.nlm.nih.gov/pubmed/26275400 http://dx.doi.org/10.1186/s12918-015-0176-9 |
_version_ | 1782385905084923904 |
---|---|
author | Wronowska, Weronika Charzyńska, Agata Nienałtowski, Karol Gambin, Anna |
author_facet | Wronowska, Weronika Charzyńska, Agata Nienałtowski, Karol Gambin, Anna |
author_sort | Wronowska, Weronika |
collection | PubMed |
description | BACKGROUND: As suggested by the origin of the word, sphingolipids are mysterious molecules with various roles in antagonistic cellular processes such as autophagy, apoptosis, proliferation and differentiation. Moreover, sphingolipids have recently been recognized as important messengers in cellular signaling pathways. Notably, sphingolipid metabolism disorders have been observed in various pathological conditions such as cancer and neurodegeneration. RESULTS: The existing formal models of sphingolipid metabolism focus mainly on de novo ceramide synthesis or are limited to biochemical transformations of particular subspecies. Here, we propose the first comprehensive computational model of sphingolipid metabolism in human tissue. Contrary to the previous approaches, we use a model that reflects cell compartmentalization thereby highlighting the differences among individual organelles. CONCLUSIONS: The model that we present here was validated using recently proposed methods of model analysis, allowing to detect the most sensitive and experimentally non-identifiable parameters and determine the main sources of model variance. Moreover, we demonstrate the usefulness of our model in the study of molecular processes underlying Alzheimer’s disease, which are associated with sphingolipid metabolism. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12918-015-0176-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4537549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45375492015-08-16 Computational modeling of sphingolipid metabolism Wronowska, Weronika Charzyńska, Agata Nienałtowski, Karol Gambin, Anna BMC Syst Biol Research Article BACKGROUND: As suggested by the origin of the word, sphingolipids are mysterious molecules with various roles in antagonistic cellular processes such as autophagy, apoptosis, proliferation and differentiation. Moreover, sphingolipids have recently been recognized as important messengers in cellular signaling pathways. Notably, sphingolipid metabolism disorders have been observed in various pathological conditions such as cancer and neurodegeneration. RESULTS: The existing formal models of sphingolipid metabolism focus mainly on de novo ceramide synthesis or are limited to biochemical transformations of particular subspecies. Here, we propose the first comprehensive computational model of sphingolipid metabolism in human tissue. Contrary to the previous approaches, we use a model that reflects cell compartmentalization thereby highlighting the differences among individual organelles. CONCLUSIONS: The model that we present here was validated using recently proposed methods of model analysis, allowing to detect the most sensitive and experimentally non-identifiable parameters and determine the main sources of model variance. Moreover, we demonstrate the usefulness of our model in the study of molecular processes underlying Alzheimer’s disease, which are associated with sphingolipid metabolism. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12918-015-0176-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-15 /pmc/articles/PMC4537549/ /pubmed/26275400 http://dx.doi.org/10.1186/s12918-015-0176-9 Text en © Wronowska et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Wronowska, Weronika Charzyńska, Agata Nienałtowski, Karol Gambin, Anna Computational modeling of sphingolipid metabolism |
title | Computational modeling of sphingolipid metabolism |
title_full | Computational modeling of sphingolipid metabolism |
title_fullStr | Computational modeling of sphingolipid metabolism |
title_full_unstemmed | Computational modeling of sphingolipid metabolism |
title_short | Computational modeling of sphingolipid metabolism |
title_sort | computational modeling of sphingolipid metabolism |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537549/ https://www.ncbi.nlm.nih.gov/pubmed/26275400 http://dx.doi.org/10.1186/s12918-015-0176-9 |
work_keys_str_mv | AT wronowskaweronika computationalmodelingofsphingolipidmetabolism AT charzynskaagata computationalmodelingofsphingolipidmetabolism AT nienałtowskikarol computationalmodelingofsphingolipidmetabolism AT gambinanna computationalmodelingofsphingolipidmetabolism |